Purchase Order 75N95D19P00197

<p>The National Institute on Aging awarded a purchase order to 10X Genomics, Inc. valued at $20,347.00 on June 16, 2017, with ultimate completion on July 16, 2017. The order is a firm fixed price acquisition with no set-aside. Work is performed in Baltimore, Maryland. The purchase order procures genomic analysis instruments, consumables, or reagent kits from 10X Genomics' single-cell and spatial transcriptomics platform portfolio.</p>

<p>The National Institute on Aging issued a purchase order to 10X Genomics, Inc. valued at $21,490.00 on December 26, 2019, for scientific equipment and instruments, with performance completed by February 28, 2020. Place of performance is Pleasanton, California. The order was issued under firm fixed pricing with no small business set-aside.</p>

<p>The National Institute on Aging issued a purchase order to 10X Genomics, Inc. valued at $24,026.00 on December 26, 2019 for scientific equipment and instruments, with completion scheduled for February 28, 2020. Performance occurs in Pleasanton, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Institute on Aging awarded a purchase order to 10X Genomics, Inc. for $20,698.94 on May 18, 2021, for laboratory supplies and reagents, with performance at Pleasanton, California and completion by June 29, 2021. The order procures reagents and consumables for genomic analysis applications, competitively awarded under firm fixed pricing with no small business set-aside.</p>

The National Institute on Aging awarded a firm fixed-price delivery order valued at $19,301.77 to 10X Genomics, Inc. for in-vitro diagnostic substance manufacturing on September 19, 2025, with an ultimate completion date of October 13, 2025. The order encompasses GEM-X Universal 3' Gene Expression V4 samples (4 units) and Chromium GEM-X Single Cell 3' Chip Kit V4 products (4 chips) to be performed at 10X Genomics' Pleasanton, California facility. This delivery order was issued without a...

The National Institute on Aging awarded a $53,016.09 firm fixed-price delivery order to 10X Genomics, Inc. for Chromium GEM-X consumable cell kits on September 19, 2025, with an ultimate completion date of October 20, 2025. The work will be performed in Pleasanton, California, where 10X Genomics maintains its headquarters. This delivery order was issued without a set-aside designation and represents specialized scientific consumables supporting genomic research initiatives. This delivery order...

The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), has awarded a firm-fixed-price purchase order totaling $115,741.50 to 10X Genomics, Inc. for the delivery of Chromium Cell Kits. These kits are used with 10X Genomics' Chromium Controller to perform single nuclei RNA and ATAC sequencing on human brain samples. The kits contain reagents and materials necessary for this specialized genomic analysis. This non-competitive award was made through a brand-name...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $54,579.75 purchase order to 10X Genomics, Inc. for Chromium Next GEM Consumables. The firm fixed price contract calls for the contractor to provide Chromium Next GEM Consumables and related services such as qualified personnel, material, equipment, and facilities to furnish the consumables. Delivery is to occur within 30 days of order receipt to a location in Baltimore, Maryland. As...

The National Institutes of Health's National Institute on Aging awarded a $170,525.50 firm fixed price purchase order to 10X Genomics, Inc. for single cell gene expression, ATAC, and multiome immune profiling. As the prime contractor, 10X Genomics will deliver these genomics services to the NIH/NIA from its Pleasanton, California facility between August 23rd and October 9th, 2023. The contract was awarded using no set aside designations. 10X Genomics will leverage its expertise in genomics tools...

The National Institutes of Health National Institute on Aging awarded a $294,880 firm-fixed price purchase order to 10X Genomics, Inc. for long read sequencing kits. The solicitation requested quotations for these products to support gene expression analysis for the agency's Center for Alzheimer's Disease and Related Dementias neurodegenerative disease research. Evaluation criteria included technical capability, price, and past performance. This requirement was set aside for small businesses...